Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples. (Q54574338)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples. |
scientific article |
Statements
Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples. (English)
1 reference
Benedict Yan
1 reference
Ee Xuan Yau
1 reference
Shoa Nian Choo
1 reference
Chee Wee Ong
1 reference
Kol Jia Yong
1 reference
Brendan Pang
1 reference
Manuel Salto-Tellez
1 reference
14 July 2011
1 reference
64
1 reference
10
1 reference
880-883
1 reference
Identifiers
1 reference